LH - NYSE

Labcorp Holdings Inc.

LH·NYSE

$258.92

+0.47%

HealthcareMedical - Diagnostics & Research

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$21.23B

EPS10.5400

P/E Ratio24.57

Earnings Date07/23/2026

lh

Accumulated Other Comprehensive Income (Loss)

Last Annual Value

-27.60M

3-Year CAGR

62%

5-Year CAGR

30%

10-Year CAGR

19%

Adjust for Inflation

Labcorp Holdings Inc. Competitors Analysis of Accumulated Other Comprehensive Income (Loss)

LH · NYSE

Company	Accumulated Other Comprehensive Income (Loss)	CAGR 3Y	CAGR 5Y	CAGR 10Y
Labcorp Holdings Inc. NYSE:LH	-27.60M	N/A	N/A	N/A
Zimmer Biomet Holdings, Inc. NYSE:ZBH	0.00	N/A	N/A	N/A
Biogen Inc. NASDAQ:BIIB	-182.00M	N/A	N/A	N/A
Incyte Corporation NASDAQ:INCY	25.46M	24.8%	N/A	N/A
United Therapeutics Corporation NASDAQ:UTHR	900.00K	N/A	N/A	N/A
STERIS plc NYSE:STE	-113.10M	N/A	N/A	N/A
Quest Diagnostics Incorporated NYSE:DGX	-27.00M	N/A	N/A	N/A
Illumina, Inc. NASDAQ:ILMN	-10.00M	N/A	N/A	N/A
West Pharmaceutical Services, Inc. NYSE:WST	-105.50M	N/A	N/A	N/A
DexCom, Inc. NASDAQ:DXCM	115.00M	N/A	196.7%	N/A
Waters Corporation NYSE:WAT	0.00	N/A	N/A	N/A

Labcorp Holdings Inc. Fair Value Envelope

LH · NYSE

Our analysis suggests that LH has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $258.92, this represents a potential HIDDEN relative to our calculated worth for Labcorp Holdings Inc..

HIDDEN

Intrinsic Value

Current Price: $258.92

Related Guides

Blog Categories

Continue your LH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.